28 completed, 7 unknown, 4 recruiting, 3 active not recruiting. 10 Phase 2, 10 Phase 3, 8 Phase 1, 7 Not applicable, 5 Phase 4.
Follow Yellow Fever: new trials by email Literature Review of Yellow Fever trials Research Report on Yellow Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated Participants Skin punch biopsy, Blood samples - Yellow Fever (Healthy Volunteers), Biopsy/Methods | Not applicable | Recruiting | Institute of Tropical Medicine, Belgium | 40 | 2026-08-10 | 2026-08-13 |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Phase 3 Single Arm, Open Study on vYF in Adults Yellow fever vaccine (live) - Yellow Fever | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 254 | 2025-10-23 | 2026-02-03 |
| A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population Yellow fever vaccine (live), Measles, combinations with mumps and rubella, live attenuated - Yellow Fever Immunization | Phase 3 | Recruiting | Sanofi | 2440 | 2025-07-11 | 2026-10-14 |
| Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults Yellow fever vaccine (live), YF vaccine (live) - Yellow Fever Immunization | Phase 3 | Completed | Sanofi | 640 | 2025-05-22 | 2026-02-02 |
| Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd, Yellow fever Vaccine (WHO prequalified) - Measles, Rubella | Phase 3 | Not yet recruiting | International Centre for Diarrhoeal Disease Research, Bangladesh | 1530 | 2025-04-01 | 2025-02-07 |
| Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination Yellow fever vaccination (STAMARIL) - HIV Infections, Yellow Fever | Not applicable | Unknown | ANRS, Emerging Infectious Diseases | 60 | 2024-11-01 | 2024-07-30 |
| A Pilot Study to Finetune Skin Processing Procedures in Recent Vaccinees, Prior to GeKoSkimm Study Initiation (GeKoSkimm-pilot) Skin biopsy - Yellow Fever | Not applicable | Completed | Institute of Tropical Medicine, Belgium | 15 | 2024-09-09 | 2025-05-09 |
| A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults AVX70120 low dose level, AVX70120 middle dose level, AVX70120 high dose level - Yellow Fever, Rabies | Phase 1 | Completed | AstriVax Therapeutics | 112 | 2024-06-16 | 2026-04-22 |
| Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination 17D - Yellow Fever, Immunization; Infection | Phase 1 / Phase 2 | Recruiting | Oregon Health and Science University | 35 | 2023-08-01 | 2025-07-31 |
| A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL STAMARIL, SII-YFV - Yellow Fever | Phase 3 | Completed | Serum Institute of India Pvt. Ltd. | 1824 | 2023-05-11 | 2025-05-07 |
| Yellow Fever Human Infection Model With YF-17D Yellow Fever Vaccine - Yellow Fever | Not applicable | Unknown | Leiden University Medical Center | 30 | 2023-02-17 | 2023-06-13 |
| Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina Serological study after yellow fever vaccination - Yellow Fever | Not applicable | Active not recruiting | Ministry of Public Health, Argentina | 361 | 2022-12-06 | 2024-12-09 |
| An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity Stamaril, Imojev, Ixiaro - Infectious Disease, Yellow Fever | Phase 2 | Unknown | Singapore General Hospital | 70 | 2022-09-28 | 2023-04-12 |
| A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants SII Yellow Fever Vaccine, STAMARIL® - Yellow Fever | Phase 3 | Unknown | Serum Institute of India Pvt. Ltd. | 2216 | 2022-09-16 | 2023-11-28 |
| Booster Vaccine for Yellow Fever 17D Yellow fever vaccine - Yellow Fever | Phase 3 | Unknown | London School of Hygiene and Tropical Medicine | 750 | 2022-05-16 | 2022-04-18 |
| Trial of an Inactivated Yellow Fever Virus Vaccine HydroVax-002 YFV, Placebo - Yellow Fever | Phase 1 | Completed | Najit Technologies, Inc. | 26 | 2022-01-13 | 2025-09-18 |
| Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection Metformin Hydrochloride, Calcium and Vitamin D - Endoplasmic Reticulum Stress, Viral Infection | Phase 2 | Completed | Singapore General Hospital | 32 | 2021-10-22 | 2024-04-17 |
| Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia Yellow fever vaccine (produced on serum-free Vero cells), Yellow fever vaccine - Yellow Fever | Phase 2 | Active not recruiting | Sanofi Pasteur, a Sanofi Company | 690 | 2021-10-07 | 2026-06-01 |
| Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA Yellow fever vaccine (produced on serum-free Vero cells), Yellow fever vaccine - Yellow Fever, Healthy Volunteers | Phase 2 | Active not recruiting | Sanofi Pasteur, a Sanofi Company | 568 | 2021-07-01 | 2026-09-03 |
Showing 20 of 44. Sign in to see all of them.
Encephalitis, Japanese (5) · Dengue (4) · Measles (3) · Chikungunya Fever (2) · Communicable Diseases (2) · HIV Infections (2) · Malaria (2) · Rabies (2) · Rotavirus Infections (2) · Rubella (2) · Severe Dengue (2) · Tetanus (2) · Typhoid Fever (2) · Virus Diseases (2)
Arbovirus Infections (44) · Flaviviridae Infections (44) · Hemorrhagic Fevers, Viral (44) · Mosquito-Borne Diseases (44) · RNA Virus Infections (44) · Flavivirus Infections (43) · Infections (43) · Vector Borne Diseases (43) · Virus Diseases (42) · Nervous System Diseases (7) · Central Nervous System Diseases (6) · Central Nervous System Infections (6) · Mononegavirales Infections (6) · Neuroinflammatory Diseases (6) · Brain Diseases (5)
Yellow Fever Vaccine (18) · Japanese Encephalitis Vaccines (2) · Biopsy, Fine-Needle (1) · Blood Specimen Collection (1) · Calcium (1) · Deuterium (1) · Floors and Floorcoverings (1) · Freeze Drying (1) · Haemophilus Vaccines (1) · Leukapheresis (1) · Measles-Mumps-Rubella Vaccine (1) · MenACWY-CRM vaccine (1) · Metformin (1) · Rabies Vaccines (1) · Seroconversion (1)
Sanofi Pasteur, a Sanofi Company (7) · Singapore General Hospital (4) · Sanofi (3) · Institute of Tropical Medicine, Belgium (2) · Serum Institute of India Pvt. Ltd. (2) · ANRS, Emerging Infectious Diseases (1) · AstriVax Therapeutics (1) · BioCryst Pharmaceuticals (1) · Centers for Disease Control and Prevention (1) · Emory University (1) · Epicentre (1) · French National Agency for Research on AIDS and Viral Hepatitis (1) · GE Healthcare (1) · GiveWell (1) · Institut Pasteur du Cambodge (1)
United States (13) · Singapore (5) · Brazil (4) · Belgium (3) · Germany (3) · Kenya (3) · Uganda (3) · France (2) · Argentina (1) · Australia (1) · Bangladesh (1) · Cambodia (1) · Canada (1) · Colombia (1) · Czechia (1)
Alison Connor, PhD (1) · Amanada Culliton (1) · Anna HE Roukens, MD PhD (1) · Carla Vizzotti (1) · Charles M Rice, PhD (1) · Christopher W Woods, MD, MPH (1) · Claude Flamand, Ph.D. (1) · Eloisa Bonfa, MD, PhD (1) · Emmanuel B Walter, MD, MPH (1) · Esper Kallas, MD, PhD (1)
PMID 31984244, PMID 10632996, PMID 15499438, PMID 15741556, PMID 16494976, PMID 17316925, PMID 18921440, PMID 19933869, PMID 20240017, PMID 20864814, PMID 21470010, PMID 24873986, PMID 25308927, PMID 25872531, PMID 30096071, PMID 30241510, PMID 33422245, PMID 34843469, PMID 36969244, PMID 37127045, PMID 37127047, PMID 39293214, PMID 39794472, PMID 39935766, PMID 39970397, PMID 41512502, PMID 41544642, PMID 41950474, PMID 42276083, PMID 42463194, PMID 42727590, PMID 6978196
U19AI057266 (2), 2009 (1), 2014 (1), 272201300017C-18-0-1 (1), U01AI141981 (1), U44AI145791 (1)